Paid Clinical Trials Maine
Discover 218 paid clinical trials in Maine. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Upadacitinib vs. AdalimumabStudy to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
Sponsor:
AbbVie
Location:
Code:
NCT05814627
Conditions
Rheumatoid Arthritis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Upadacitinib
Adalimumab
Upadacitinib Matching Placebo
Adalimumab Matching Placebo
XL092 & NivolumabStudy of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma
Sponsor:
Exelixis
Location:
Code:
NCT05678673
Conditions
Non-Clear Cell Renal Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
XL092
Nivolumab
Sunitinib Malate
Neratinib & PalbociclibTesting the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT06126276
Conditions
Malignant Female Reproductive System Neoplasm
Malignant Solid Neoplasm
Recurrent Malignant Female Reproductive System Neoplasm
Recurrent Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biopsy Procedure
Biospecimen Collection
Computed Tomography
Echocardiography Test
Magnetic Resonance Imaging
Amivantamab-SubcutaneousTargeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Sponsor:
SWOG Cancer Research Network
Location:
Code:
NCT06116682
Conditions
Lung Non-Small Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Amivantamab
Biospecimen Collection
Computed Tomography
Magnetic Resonance Imaging
SelinexorSelinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
Sponsor:
Karyopharm Therapeutics Inc
Location:
Code:
NCT05611931
Conditions
Endometrial Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Selinexor
Matching Placebo for selinexor
MicronutrientsMicronutrients as Adjunctive Treatment for Bipolar Disorder
Sponsor:
Eastern Maine Medical Center
Location:
Code:
NCT03541031
Conditions
Bipolar Disorder
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Micronutrient & Fish oil
Olive oil & Safflower oil
TriptorelinTriptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Sponsor:
Children's Oncology Group
Location:
Code:
NCT06513962
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: Female
Age: 0 - 39
Healthy Volunteers: Not accepted
Interventions
Best Practice
Biospecimen Collection
Electronic Health Record Review
Survey Administration
Triptorelin Pamoate
SaruparibSaruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents
Sponsor:
AstraZeneca
Location:
Code:
NCT06120491
Conditions
Metastatic Castration-Sensitive Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Saruparib
Placebo
Abiraterone Acetate
Darolutamide
Enzalutamide
Paclitaxel & IpatasertibStudy of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT05554380
Conditions
Locally Advanced Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm
Unresectable Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biopsy Procedure
Biospecimen Collection
Computed Tomography
Ipatasertib
Magnetic Resonance Imaging
Apalutamide with Hormone TherapyTesting the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer
Sponsor:
NRG Oncology
Location:
Code:
NCT04134260
Conditions
Prostate Adenocarcinoma
Stage I Prostate Cancer AJCC v8
Stage II Prostate Cancer AJCC v8
Stage IIA Prostate Cancer AJCC v8
Stage IIB Prostate Cancer AJCC v8
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Apalutamide
Hormone Therapy
Quality-of-Life Assessment
Questionnaire Administration
Radiation Therapy